Lunar's move into dedicated MRI imaging is proceeding smoothly.The ink was barely dry on Lunar's agreement for exclusive NorthAmerican distribution rights to Esaote Biomedica's Artoscan dedicatedMRI extremity scanner when the unit received 510(k)
Lunar's move into dedicated MRI imaging is proceeding smoothly.The ink was barely dry on Lunar's agreement for exclusive NorthAmerican distribution rights to Esaote Biomedica's Artoscan dedicatedMRI extremity scanner when the unit received 510(k) marketingclearance from the Food and Drug Administration.
The FDA's action gives Lunar the go-ahead to show Artoscanas a commercial product at the Radiological Society of North Americaconference next month.
Esaote of Italy unveiled Artoscan at last year's RSNA meetingand the system will be shown in Lunar's booth this year (SCAN10/6/93 and 10/7/92). Lunar, of Madison, WI, will market the 0.2-teslapermanent magnet to hospitals looking for a low-cost unit to provideextremity scanning while leaving more expensive MRI systems openfor full-body imaging.
Artoscan gets the jump on niche competitor Magna-Lab, whichis also developing an extremity scanner but has not yet filedfor FDA approval. Magna-Lab plans to bring one of its scannersto this year's RSNA meeting and will show images from the unit,according to a company spokesperson.
An initial prototype of Magna-Lab's three-sided head and extremityimager, the Magna-SL, was shown at the 1992 RSNA exhibition (SCAN12/2/92).
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.